StockData
Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc. (TNGX) stock

TNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30128% above fair value
$22.11−2.06 (-8.52%)

Close on Nov 17, 2026Market cap $3.73BP/E –Yield –

Tango Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Tango Therapeutics's total assets was $1.07B at Jun 30, 2026. For fiscal 2025 it was $398.69M, up 26.0% from the year before. The highest annual figure on record is $500.16M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$398.69M+26.0%
FY2024Dec 31, 2024$316.49M-21.4%
FY2023Dec 31, 2023$402.57M-7.8%
FY2022Dec 31, 2022$436.47M-12.7%
FY2021Dec 31, 2021$500.16M+141.3%
FY2020Dec 31, 2020$207.25M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.07B+351.4%
Q1 FY2026Mar 31, 2026$435.79M+58.9%
Q4 FY2025Dec 31, 2025$398.69M+26.0%
Q3 FY2025Sep 30, 2025$210.14M-40.4%
Q2 FY2025Jun 30, 2025$237.89M-37.6%
Q1 FY2025Mar 31, 2025$274.31M-32.5%
Q4 FY2024Dec 31, 2024$316.49M-21.4%
Q3 FY2024Sep 30, 2024$352.42M-17.7%
Q2 FY2024Jun 30, 2024$381.45M+0.6%
Q1 FY2024Mar 31, 2024$406.22M+0.6%
Q4 FY2023Dec 31, 2023$402.57M-7.8%
Q3 FY2023Sep 30, 2023$428.19M-7.7%
Q2 FY2023Jun 30, 2023$379.33M-15.4%
Q1 FY2023Mar 31, 2023$403.77M-14.4%
Q4 FY2022Dec 31, 2022$436.47M-12.7%
Q3 FY2022Sep 30, 2022$464.16M-12.4%
Q2 FY2022Jun 30, 2022$448.40M+167.6%
Q1 FY2022Mar 31, 2022$471.53M+180.2%
Q4 FY2021Dec 31, 2021$500.16M+141.3%
Q3 FY2021Sep 30, 2021$530.14M+214.8%
Q2 FY2021Jun 30, 2021$167.55M–
Q1 FY2021Mar 31, 2021$168.26M–
Q4 FY2020Dec 31, 2020$207.25M–
Q3 FY2020Sep 30, 2020$168.38M–

More Tango Therapeutics figures

See a number that looks wrong?